Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/CHEBI_6384
http://purl.obolibrary.org/obo/CHEBI_6384
|
|---|---|
| Preferred Name | latanoprost |
| Synonyms |
C26H40O5
isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprost-5-en-1-oate
latanoprostum
latanoprost
propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate
PhXA 41
propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate
isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate
Xalatan
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | latanoprost
|
|---|---|
| label | latanoprost
|
| ATCCode | S01EE01
|
| Definition | A prostaglandin Falpha that is the isopropyl ester prodrug of latanoprost free acid. Used in the treatment of open-angle glaucoma and ocular hypertension.
|
| has effect |
See more
See less
|
| has pharmacological target | |
| activates | |
| type | |
| has role | |
| InChIKey | InChIKey=GGXICVAJURFBLW-CEYXHVGTSA-N
|
| AHFScode | 52:92.00
|
| Synonym | C26H40O5
isopropyl (5Z,9alpha,11alpha,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinorprost-5-en-1-oate
latanoprostum
latanoprost
propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate
PhXA 41
propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate
isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate
Xalatan
See more
See less
|
| xref |
CiteXplore:22289196
CiteXplore:22320418
CiteXplore:21278589
KEGG DRUG:D00356
CiteXplore:22275828
Wikipedia:http://en.wikipedia.org/wiki/Latanoprost
Wikipedia:Latanoprost
CiteXplore:21858678
CiteXplore:22323882
National Drug Code Directory:0013-8303-01
HMDB:HMDB14792
RxList:http://www.rxlist.com/cgi/generic/latanoprost.htm
CiteXplore:22275814
BindingDB:50150899
CiteXplore:22167539
Beilstein:5912370
CiteXplore:22040280
CiteXplore:22289195
Reaxys:5912370
PDRhealth:http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/xal1490.shtml
PharmGKB:PA164774763
Drugs.com:http://www.drugs.com/cdi/latanoprost-drops.html
Drugs Product Database (DPD):2231493
CiteXplore:22167538
CASRN:130209-82-4
CiteXplore:22283238
CiteXplore:22049909
ChEBI:6384
DrugBank:DB00654
See more
See less
|
| CASRN | 130209-82-4
|
| prefixIRI | obo2:CHEBI_6384
|
| is transported by | |
| related with | |
| SMILES |
CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1
CC(C)OC(=O)CCC\\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1
|
| may interact with | |
| DBname | latanoprost
|
| InChI | InChI=1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1
|
| DBBrand |
xalatan fixed flow device
xalatan
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |